EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

SARS-CoV-2 testing uptake and its determinants in six ethnic groups living in Amsterdam, the Netherlands: a registry-based study within the HELIUS cohort

Sophie L Campman, Anders Boyd, Nina van Wilgen, Felix P Chilunga iD, Liza Coyer, Janke Schinkel, Charles Agyemang, Henrike Galenkamp iD, Anitra D M Koopman, Jelle Koopsen, Matthijs Welkers, Karien Stronks und 1 weitere

European Journal of Public Health · 10.06.2026 · 36 (4)

DOI: 10.1093/eurpub/ckag081 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Public Health, online erschienen am 08.07.2026. Verfasst von Sophie L Campman und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: COVID-19, Ethnicity, COVID-19 Testing, COVID-19 Nucleic Acid Testing. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ZonMw, the Public Health Service of Amsterdam, Amsterdam UMC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diagnostic testing was key in preventing transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the pre-vaccination era of the coronavirus disease 2019 pandemic. This study compared SARS-CoV-2 polymerase chain reaction (PCR) testing uptake and its determinants across six ethnic groups in Amsterdam, the Netherlands. We analyzed data from the population-based Healthy Life in an Urban Setting cohort linked to SARS-CoV-2 testing registry data from the Public Health Service of Amsterdam. Testing uptake was defined as completing at least one SARS-CoV-2 PCR test before 6 September 2021. We examined the association between ethnicity and testing uptake, and assessed determinants of testing uptake per ethnic group, using logistic regression while correcting for ethnic-specific age and sex distributions in Amsterdam. We included 19 006 participants (median age 53 years; 57% female). Testing uptake ranged from 25.3% (95% confidence interval (CI) = 23.1%–27.5%) in the Ghanaian to 52.2% (95% CI = 50.3%–54.1%) in the Turkish group. Individuals of Turkish origin [adjusted odds ratio (aOR) = 1.12, 95% CI = 1.01–1.23] were more likely, while those of African Surinamese (aOR = 0.88, 95% CI = 0.79–0.97) and particularly Ghanaian (aOR = 0.35, 95% CI = 0.30–0.40) origin less likely to be tested compared to those of Dutch origin. Younger age and perceived work or home-related stress were associated with testing uptake across most ethnic groups. Other determinants were specific to certain groups. SARS-CoV-2 testing uptake varied slightly across most ethnic groups in Amsterdam with the highest uptake among individuals of Turkish origin but was remarkably lower among individuals of Ghanaian origin. Given the diversity of identified determinants, testing strategies should be tailored to the needs of specific groups.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19EthnicityCOVID-19 TestingCOVID-19 Nucleic Acid TestingPatient Acceptance of Health CareHumansNetherlandsFemaleMiddle AgedMaleRegistriesAdultSARS-CoV-2AgedCohort Studies

Stichwörter der Autor:innen

COVID-19PCRSARS-CoV-2ethnicitytesting uptake

Autor:innen und Institutionen

  • Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, The Netherlands.
  • Department of Infectious Diseases, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.
  • Amsterdam Institute for Immunology and Infectious Diseases, Amsterdam, The Netherlands.
  • Stichting hiv monitoring, Amsterdam, The Netherlands.
  • Department of Public and Occupational Health, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.
  • Amsterdam Public Health, Health Behaviors and Chronic Diseases, Amsterdam, The Netherlands.

ORCID-Profile: Felix P Chilunga, Henrike Galenkamp

Förderung

  • ZonMw
  • the Public Health Service of Amsterdam
  • Amsterdam UMC
  • Academic Medical Center and the Public Health Service of Amsterdam
  • Dutch Heart Foundation
  • European Union (FP-7)
  • European Fund for the Integration of non-EU immigrants (EIF)

Zitieren

APA

Campman, S. L., Boyd, A., van Wilgen, N., Chilunga, F. P., Coyer, L., Schinkel, J., Agyemang, C., Galenkamp, H., Koopman, A. D. M., Koopsen, J., Welkers, M., Stronks, K., & Prins, M. (2026). SARS-CoV-2 testing uptake and its determinants in six ethnic groups living in Amsterdam, the Netherlands: a registry-based study within the HELIUS cohort. European Journal of Public Health, 36(4). https://doi.org/10.1093/eurpub/ckag081

Vancouver

Campman SL, Boyd A, van Wilgen N, Chilunga FP, Coyer L, Schinkel J, et al. SARS-CoV-2 testing uptake and its determinants in six ethnic groups living in Amsterdam, the Netherlands: a registry-based study within the HELIUS cohort. European Journal of Public Health. 2026;36(4). doi:10.1093/eurpub/ckag081

BibTeX
@article{Campman2026,
  author = {Campman, Sophie L and Boyd, Anders and van Wilgen, Nina and Chilunga, Felix P and Coyer, Liza and Schinkel, Janke and Agyemang, Charles and Galenkamp, Henrike and Koopman, Anitra D M and Koopsen, Jelle and Welkers, Matthijs and Stronks, Karien and Prins, Maria},
  title = {SARS-CoV-2 testing uptake and its determinants in six ethnic groups living in Amsterdam, the Netherlands: a registry-based study within the HELIUS cohort},
  journal = {European Journal of Public Health},
  year = {2026},
  volume = {36},
  number = {4},
  doi = {10.1093/eurpub/ckag081}
}
Kostenlos starten →